These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30293118)

  • 1. Progress in gene therapy using oncolytic vaccinia virus as vectors.
    Yang X; Huang B; Deng L; Hu Z
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2433-2440. PubMed ID: 30293118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.
    Guo ZS; Lu B; Guo Z; Giehl E; Feist M; Dai E; Liu W; Storkus WJ; He Y; Liu Z; Bartlett DL
    J Immunother Cancer; 2019 Jan; 7(1):6. PubMed ID: 30626434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy.
    Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M
    Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
    Rojas JJ; Van Hoecke L; Conesa M; Bueno-Merino C; Del Canizo A; Riederer S; Barcia M; Brosinski K; Lehmann MH; Volz A; Saelens X; Sutter G
    Mol Ther; 2024 Jul; 32(7):2406-2422. PubMed ID: 38734899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in combination therapy of oncolytic vaccinia virus.
    Mirbahari SN; Da Silva M; Zúñiga AIM; Kooshki Zamani N; St-Laurent G; Totonchi M; Azad T
    Front Immunol; 2024; 15():1272351. PubMed ID: 38558795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
    Verardi PH; Titong A; Hagen CJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
    Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
    PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus.
    Huang Z; Liu M; Huang Y
    Discov Med; 2020; 30(159):39-48. PubMed ID: 33357361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
    Mansfield DC; Kyula JN; Rosenfelder N; Chao-Chu J; Kramer-Marek G; Khan AA; Roulstone V; McLaughlin M; Melcher AA; Vile RG; Pandha HS; Khoo V; Harrington KJ
    Gene Ther; 2016 Apr; 23(4):357-68. PubMed ID: 26814609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apoptin enhances the oncolytic activity of vaccinia virus].
    Kochneva GV; Babkina IN; Lupan TA; Grazhdantseva AA; Iudin PV; Sivolobova GF; Shvalov AN; Popov EG; Babkin IV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2013; 47(5):842-52. PubMed ID: 25509357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review.
    Li M; Zhang M; Ye Q; Liu Y; Qian W
    Cancer Biol Med; 2023 Aug; 20(9):646-61. PubMed ID: 37615308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of the drug oncolytic immunotherapy based on vaccinia viruses (Vaccinia virus, Orthopoxvirus, Chordopoxvirinae, Poxviridae) against breast cancer.].
    Bauer TV; Tregubchak TV; Maksyutov AZ; Kolosova IV; Maksyutov RA; Gavrilova EV
    Vopr Virusol; 2020; 65(1):49-56. PubMed ID: 32496721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic Viruses: Therapeutics With an Identity Crisis.
    Breitbach CJ; Lichty BD; Bell JC
    EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation oncolytic vaccinia vectors.
    Thorne SH
    Methods Mol Biol; 2012; 797():205-15. PubMed ID: 21948478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic vaccinia virus and cancer immunotherapy.
    Xu L; Sun H; Lemoine NR; Xuan Y; Wang P
    Front Immunol; 2023; 14():1324744. PubMed ID: 38283361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic virus therapy: A new era of cancer treatment at dawn.
    Fukuhara H; Ino Y; Todo T
    Cancer Sci; 2016 Oct; 107(10):1373-1379. PubMed ID: 27486853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.